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ABSTRACT
Objective A core feature of e-prescribing is the
electronic exchange of prescription data between
physician practices and pharmacies, which can
potentially improve the efﬁciency of the prescribing
process and reduce medication errors. Barriers to
implementing this feature exist, but they are not well
understood. This study’s objectives were to explore
recent physician practice and pharmacy experiences
with electronic transmission of new prescriptions and
renewals, and identify facilitators of and barriers to
effective electronic transmission and pharmacy
e-prescription processing.
Design Qualitative analysis of 114 telephone interviews
conducted with representatives from 97 organizations
between February and September 2010, including 24
physician practices, 48 community pharmacies, and
three mail-order pharmacies actively transmitting or
receiving e-prescriptions via Surescripts.
Results Practices and pharmacies generally were
satisﬁed with electronic transmission of new
prescriptions but reported that the electronic renewal
process was used inconsistently, resulting in inefﬁcient
workarounds for both parties. Practice communications
with mail-order pharmacies were less likely to be
electronic than with community pharmacies because of
underlying transmission network and computer system
limitations. While e-prescribing reduced manual
prescription entry, pharmacy staff frequently had to
complete or edit certain ﬁelds, particularly drug name
and patient instructions.
Conclusions Electronic transmission of new
prescriptions has matured. Changes in technical
standards and system design and more targeted
physician and pharmacy training may be needed to
address barriers to e-renewals, mail-order pharmacy
connectivity, and pharmacy processing of
e-prescriptions.
INTRODUCTION
Physician use of electronic prescribing (e-prescribing)
systems to generate legible and complete prescrip-
tions could potentially reduce medication errors and
improve physician practice and pharmacy efﬁciency
by mitigating pharmacists’ need for clariﬁcation.
1
Another important e-prescribing feature is the two-
way electronic exchange of prescription data
between physicians and pharmacies. Physicians can
transmit new prescriptions directly from their
e-prescribing systems into pharmacy information
systems as well as respond to pharmacies’ electronic
renewal authorization requests once medication
reﬁlls are exhausted (see box 1 and ﬁgure 1).
Although research on the effects of electronic
transmission is limited, physicians appear to save
time, primarily from electronic renewals.
2 3 More-
over, electronic transmission of both new prescrip-
tions and renewals has the potential to streamline
workﬂow for other practice and pharmacy staff and
minimize interruptions from phone and fax
communications.
2e7 Pharmacy staff also may save
time processing prescriptions that do not have to be
entered manually.
7e9 Reducing manual entry has
the potential to lower the rate of prescription errors
as well.
71 0 e12
Despite these and other potential e-prescribing
beneﬁts, e-prescription volume has been low,
although it is growing as physicians respond to
Federal ﬁnancial incentive programs.
13 14 Medicare
began paying bonuses to qualifying physicians
using electronic health record (EHR) or stand-alone
e-prescribing systems under the Medicare Elec-
tronic Prescribing Incentive Program in 2009.
Physicians can qualify for substantially larger
payments through the Medicare and Medicaid
Electronic Health Records Incentive Programs
(EHR Incentive Programs), starting in 2011. To
receive incentives, physicians must fulﬁll require-
ments to demonstrate that they are meaningful
users of certiﬁed EHRs, including generating and
transmitting more than 40% of all prescriptions to
pharmacies electronically, excluding prescriptions
for controlled substances. This threshold is
expected to rise as program requirements become
more stringent.
15 E-prescribing volume likely will
grow further as new standards are implemented to
support e-prescribing of controlled substances.
To maximize the beneﬁts of electronic prescrip-
tion transmission, including improved efﬁciency and
reduced medication errors, both physician practice
and pharmacy staff must use the feature routinely.
However, not all physicians who use health infor-
mation technology (IT) applications to generate
prescriptions have systems that support electronic
transmission of new prescriptions or renewals, and
even when these features are available, physicians
do not always use them.
6 13 16e21 Similarly, not all
community and mail-order pharmacies have the
ability to receive new prescriptions electronically or
to send electronic renewal requests, and even if they
do, staff may not use these features routinely.
81 3
Pharmacies have faced additional challenges,
including delays in receiving or being alerted to new
e-prescriptions, continued need to manually enter or
edit prescription data, and the need to follow-up
with physicians to resolve gaps, errors, or lack of
clarity in e-prescriptions.
781 02 2
Most studies that identify e-prescribing barriers
are based on data from 2007 or earlier and do not
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Research and applicationsexplore electronic transmission in detail. This study focuses on
how electronic transmission features are being used for new
prescriptions and renewals, the facilitators of and barriers to use,
and the effects on pharmacies’ prescription processing. The
study also explores strategies to support more effective use of
these features. The data were collected as part of a broader
qualitative research project to better understand recent experi-
ences of physician practices and pharmacies using advanced
e-prescribing features.
23
METHODS
Participants
Sampling frames of physician practices and community phar-
macies actively using e-prescribing in 12 Community Tracking
Study (CTS) sites were developed from lists of physicians and
pharmacies registered with Surescriptsdthe dominant elec-
tronic prescription transmission network in the USAdwhich
were obtained from the company’s website. Since 1996, the CTS
has monitored healthcare market changes in 12 communities
through periodic site visit interviews with leaders of local
healthcare organizations, including physician practices.
24 CTS
sites were selected to be nationally representative of metropol-
itan areas with populations over 200000 (see table 1 for sites).
Stratifying the sampling frame by CTS sites allowed compari-
sons of practice and pharmacy e-prescribing experiences within
and across markets that vary by factors that may be related to
e-prescribing experiences, including relative market shares of
local and national pharmacies, e-prescription volume, and state
e-prescribing regulations.
25 26
Physician practices that participated in the CTS previously or
were suggested by CTS respondents were selected purposefully
from the sampling frame to vary in size, specialty, and type of
e-prescribing system (EHR vs stand-alone). In each practice, the
CTS contact was asked to identify an experienced physician
user, and an additional respondent such as an IT manager or
nurse if needed, to capture both clinical and operational
perspectives on the practice’s e-prescribing experiences.
Because less research exists on pharmacy e-prescribing expe-
riences, pharmacies were oversampled relative to physician
practices to support more in-depth study. The pharmacy
sampling frame was stratiﬁed by local and national ownership
(see table 2 for more detail). While a few national companies
account for a substantial proportion of pharmacy locations in
the USA, the same information system is typically used across
locations, so locally owned pharmacies were oversampled to
capture more variation in e-prescribing experiences. The
corporate headquarters of some national companies were
contacted to select pharmacy locations to participate. Other
Box 1 Electronic prescription transmission
When physician practices and pharmacies use the e-prescribing
routing features of their computer systems, the prescription data
are transmitted as follows (see ﬁgure 1):
New prescriptions
Once a physician completes a new prescription and selects the
option to send it electronically, it is transmitted through the
e-prescribing vendor to the electronic prescription routing inter-
mediary’s network. From there, the prescription is typically
routed through the pharmacy system vendor or the pharmacy’s
central corporate server to the chosen pharmacy location. Staff
are alerted to the e-prescription arrival on the pharmacy system’s
display screen, for example, with an icon or new work log entry,
and the prescription is opened in the work queue for processing.
If the pharmacy does not accept e-prescriptions, the intermediary
converts the prescription to a fax.
Renewals
Once reﬁlls are exhausted, at the request of the patient, the
pharmacy sends an electronic renewal authorization requestd
also known to users as a ‘reﬁll’ requestdto physicians for
approval. The renewal authorization request is logged into the
pharmacyandpracticesystemmessagequeuespendingapproval.
The physician reviews the request and has three options: (1) to
approve it astransmitted; (2) to make changes to alimited number
of ﬁelds, suchas numberof reﬁlls; or(3)to denyit. Authorization is
sent back to the pharmacy as a new prescription that is linked to
the old prescription by a unique identifying code. This linkage
allows the pharmacy system to auto-populate the necessary data
from the existing prescription. If the physician denies the request,
the physician typically selects a reason, such as ‘following with
a new prescription’ for a change in dosage or to make other
substantial prescription modiﬁcations. The new prescription
references the prescription number of the denied request to allow
the pharmacy staff to delete the initial renewal request. Alterna-
tively, the physician can initiate an e-renewal, in which case the
pharmacist handles the renewal as a new prescription.
Figure 1 E-prescribing information
exchange. Source: adapted from Bell
DS, Straus SG, Belson D, et al. A toolset
for e-prescribing implementation in
physician ofﬁces; ﬁgure 2.1 (prepared
by RAND Corporation under contract
no. HHSA 290-2006-00017, TO #4,
AHRQ publication no. 11-0102-EF).
Rockville, MD: Agency for Healthcare
Research and Quality, 2011 (in press).
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Research and applicationspharmacies were selected through recommendations from
professional associations and physician respondents or recruited
directly. In each pharmacy location, the pharmacist-in-charge
was asked to participate. Other experts, including representa-
tives of vendors, e-prescribing intermediaries, and state phar-
macy associations, were identiﬁed to provide context for the
user interviews.
Data collection and analysis
Six researchers formed two-person teams, consisting of a lead
interviewer and a note-taker, to conduct 30e60 min tele-
phone interviews between February and September 2010. Semi-
structured protocols were tailored to each respondent type and
included questions on IT systems; implementation and use of
e-prescribing features, including electronic routing of new
prescriptions and renewals; and pharmacy processing of
e-prescriptions. (See supplementary online appendix 1 for
selected protocols.) Interview team members jointly reviewed
the interview transcriptions for accuracy.
The six-person research team used an iterative process to
develop and reﬁne emerging themes and to ensure data satura-
tion based on a rolling review of the transcripts. Codes were
developed using the ‘integrated’ approach described by Bradley
and colleagues in which a ‘start list’ is developed from the
literature and then reﬁned based on the data.
27e29 The interview
transcripts were coded and further analyzed by the four study
authors using Atlas.ti qualitative software. Data tables were
used along with the transcripts to systematically conﬁrm and
further reﬁne themes, and weigh the evidence supporting each
ﬁnding.
28 The principal investigator and another researcher ﬁrst
summarized a small sample of transcripts in preliminary table
shells developed using project themes and codes, then met to
resolve discrepancies and modify the shells as needed. The two
other researchers completed summaries of the remaining prac-
tice and pharmacy transcripts, respectively; all transcripts and
summaries were also reviewed by the principal investigator. The
authors met regularly to resolve conﬂicts and reach consensus on
the data tables and study ﬁndings.
27
RESULTS
A total of 114 telephone interviews were conducted with
representatives of 97 organizations. Twenty-four physician
practices participated, two in each CTS site. Forty-eight
community pharmacies also participated, divided between local
and national companies, with four pharmacies per site. For each
participating national chain drug store, pharmacists were
interviewed at a minimum of three different locations. National
respondents included representatives of three mail-order phar-
macies and three chain pharmacy headquarters and 21 other
experts.
Tables 1 and 2 provide more descriptive information on
participating physician practices and community pharmacies,
Table 1 Characteristics of participating physician
practices
Characteristic
Number of
practices (N[24)*
Specialty
Primary care 16
Medical or surgical specialty 5
Multispecialty 3
Number of physicians
1e91 2
10e49 7
50e500 5
Practice ownership
Physician 17
Hospital 6
Faculty practice 1
Type of e-prescribing systemy
Part of electronic health record system 17
Stand-alone system 7
Number of years prescriptions sent electronically
<21 2
2+ 12
Estimated percentage of prescriptions sent electronically
<70 6
70+ 17
Unknown 1
*Two practices were interviewed in each of the 12 Community Tracking
Study (CTS) sites: Boston; Cleveland; Greenville, South Carolina;
Indianapolis; Lansing, Michigan; Little Rock, Arkansas; Miami; northern
New Jersey; Orange County, California; Phoenix; Seattle; and Syracuse,
New York.
yTwelve different commercial e-prescribing vendors were represented.
Among the 17 practices using electronic health record systems, vendors
included: Allscripts (4), eClinicalWorks (2), Epic (3), GE Centricity (2),
GEMMS, McKesson, MedENT, NextGen (2), and one homegrown
system. Stand-alone e-prescribing system vendors used in the remaining
seven practices included: Allscripts (2), InstantDX, Prematic, RelayHealth
(2) and DrFirst, which was integrated into a Greenway Medical
Technologies electronic health record system.
Table 2 Characteristics of participating community pharmacies
Characteristic
Number of community
pharmacies (N[48)*
Ownership
Local (within state)
Independentdthree or fewer locations 16
Independentdregional/local chain drug store,
supermarket, provider-owned, and other
8
Total 24
National (multi-state)
Chain drug store 15
Supermarket 3
Mass merchant 6
Total 24
Estimated average prescriptions per week
200e750 11
751e1750 16
>1750 16
Unknown 5
Pharmacy information system
Home-grown 19
Commercial vendory 29
Number of years prescriptions received electronically
<23 2
2+ 13
Unknown 3
Estimated percentage of prescriptions received electronically
#5% 15
6%e14% 11
15%e24% 8
25%+ 11
Unknown 3
*Four pharmacies were interviewed in each of the 12 Community Tracking Study (CTS)
sites: Boston; Cleveland; Greenville, South Carolina; Indianapolis; Lansing, Michigan; Little
Rock, Arkansas; Miami; northern New Jersey; Orange County, California; Phoenix; Seattle;
and Syracuse, New York.
yThirteen different pharmacy information system vendors were represented among the 29
participating pharmacies using commercial systems, including: McKesson (including
Enterprise, PharmaServ, and Condor products) (11), QS/1 (4), PDX (3), Transaction Data
Systems Rx30 (2), as well as nine other vendors.
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Research and applicationsrespectively. About 70% of practices used EHRs, while the
remainder used stand-alone e-prescribing systems, closely
representative of the national distribution of physicians regis-
tered on Surescripts in 2009.
13 Practices and pharmacies used
a variety of system vendors and the sample included both early
and later adopters.
More than two-thirds of practices estimated they sent at least
70% of prescriptions electronically. Physicians selected other
transmission modesdsuch as print, fax, or phonedwhen
necessary, for example, when prescribing controlled substances,
when a patient did not need a prescription ﬁlled immediately or
expressed a preference for a printed prescription, or when
a pharmacy was unable to receive e-prescriptions.
In contrast, more than half of community pharmacists esti-
mated their pharmacy received <15% of prescriptions electron-
ically, with national pharmacies more likely to receive a higher
proportion. This rate was low, in part, because many physicians
did not transmit any prescriptions electronically. Moreover,
community pharmacies noted receiving numerous computer-
generated prescriptions that were faxed or printed, sometimes
outnumbering e-prescriptions.
Physician and pharmacy respondents generally noted overall
satisfaction with e-prescribing and perceived improvements in
efﬁciency and patient safety. However, respondents identiﬁed
some substantial challenges to fully realizing the anticipated
beneﬁts from the transmission and processing of e-prescriptions.
Electronic transmission
New prescriptions
Most respondents expressed satisfaction with the electronic
transmission of new prescriptions. Despite the complexity of
prescription routing through multiple parties, respondents
reported true transmission failures were rare. However, about
one-third each of physician practices and community pharma-
cies noted that, on a daily basis, patients arrived to pick up
orders before the pharmacy had received the e-prescription.
Practice respondents were more likely to attribute the problem
to pharmacy staff being inadequately trained to identify new
e-prescriptions, with problems reportedly diminishing as phar-
macy staff gained e-prescribing experience. Pharmacists,
however, believed that incoming e-prescriptions were easily
identiﬁed and were more likely to point to physician delays
in transmitting the prescriptions or, less commonly, trans-
mission to the wrong pharmacy. Pharmacies typically resolved
transmission problems by calling physicians for verbal orders.
Prescription renewals
Physicians and community pharmacists found that the elec-
tronic renewal process was not as consistently successful as new
prescription routing and was more difﬁcult to integrate into
organization workﬂows. Respondents, nonetheless, highlighted
the time-saving advantages of the electronic renewal process
when working properly. A physician respondent from a small
family-medicine practice noted, ‘Previously, someone had to get
the fax, distribute it, get the approval and call or fax it in..
Now the physician gets. ar e ﬁll request to their inbox right
away and can deny or accept it in seconds. It eliminates hand-
offs. So instead of 24 h, the turnaround time is an hour.’ On the
pharmacy side, according to a manager of a mass-merchant
pharmacy, ‘The physician sends me back the exact same
everything.. The e-prescription is married to something in my
system, so ﬁve keystrokes and it’s ready to go.’
While both physicians and pharmacies stand to beneﬁt from
the increased efﬁciency of electronic renewals, more than
one-quarter of the participating community pharmacies,
including 11 of the 24 local pharmacies and three national
pharmacies, did not send electronic renewal authorization
requests. Eight of these pharmacies lacked the functionality, and
the rest chose not to use the feature, mainly to avoid Surescripts
transaction fees. Similarly, one-third of physician practices were
not set up to receive e-renewal requests or received them infre-
quently.
Among practices that did receive e-renewal requests, respon-
dents identiﬁed ways in which the renewal process broke
down, resulting in inefﬁciencies. For example, they reported that
local and national pharmacies able to receive e-prescriptions
from the practice did not consistently request renewal authori-
zations electronically and sometimes sent multiple requests for
the same prescription using different means, even after the
physician had responded electronically. As one physician
explained, ‘Sometimes the patient will call, the pharmacy will
fax, and [send something via] Surescripts, all for the same
patient, the same prescription, on the same day. That is
cumbersome.’
Pharmacists explained that follow-up is necessary if physi-
cians do not respond in a timely way, for example, within 24 h
as Surescripts recommends. A pharmacist from a national
pharmacy chain explained, ‘Our system automatically generates
the request. If they [don’t] respond, that’s where we run into
problems. We fax the next day because we can’t send a duplicate
request electronically.’ Another pharmacist noted that his
system is set up to automatically resend an e-ﬁll request every
72 h until the initial request is marked as complete.
Inconsistent pharmacy renewal request methods reinforced
inconsistent modes of response from physician ofﬁces, making it
more difﬁcult for both parties to ensure that the prescription is
ﬁlled and that their systems are updated. Pharmacists reported
that physicians often approve electronic requests by fax or
phone. They also noted that physicians often mistakenly deny
the request and then send the same prescription as a new order.
In contrast, multiple physician respondents noted that they
typically try to respond to all renewal requests electronically,
regardless of delivery mode, to capture the prescription in their
e-prescribing system and to convey to the pharmacy that they
are enabled for electronic renewals.
When physicians transmitted prescription renewals without
responding to a pharmacy request, pharmacists typically had to
enter the prescriptions as if they were new, losing efﬁciencies
from auto-population. Both pharmacies and physician practices
also had to manually update their systems’ message queues, for
example, by deleting any pending requests.
Mail-order pharmacy connectivity
Electronic routing for new prescriptions and renewals with mail-
order pharmacies posed additional challenges, with about three-
quarters of the physician practices experiencing difﬁculties.
Many practices were not sure which mail-order pharmacies
accepted e-prescriptions and believed that, even when a mail-
order company did accept them, the process was unreliable.
According to a nurse in one practice, ‘We are nervous about
sending electronically to mail orders. The success rate isn’t
high.. If it doesn’t go through, I will fax it. We can lose four or
ﬁve days though. ﬁnding out that it never went through.’
Respondents also largely noted that renewal authorization
requests from mail-order pharmacies were received only by fax.
In response to these challenges, some practices ﬁrst tried elec-
tronic routing for new prescriptions or renewal responses,
followed by faxing or printing the prescription if unsuccessful.
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routinely faxing or printing all mail-order prescriptions.
Practice respondents were surprised by these challenges,
expecting electronic routing to function identically for
community and mail-order pharmacies. However, as mail-order
pharmacy respondents explained, few e-prescribing vendors that
were Surescripts-certiﬁed to e-prescribe with community phar-
macies were also certiﬁed for new prescriptions with mail-order
pharmacies, and even fewer were certiﬁed for mail-order
renewals. As a result, while some practice respondents believed
they were sending prescriptions electronically when they
selected mail-order pharmacies from the e-prescribing directory,
the mail-order pharmacies noted most e-prescriptions from
Surescripts were delivered by fax. For the same reason, most
mail-order renewal requests also were sent by fax. These
connectivity barriers arose because the new Surescripts organi-
zation, formed from a merger of SureScripts and RxHub in 2008,
continued to maintain two legacy transmission networks.
Some mail-order pharmacies addressed these barriers by
converting all e-prescriptions to images and processing them
with fax and paper prescriptions in a single workﬂow, while
others maintained dual workﬂows, processing e-prescriptions
separately. Since the time of the interviews, transmission
network changes have been implemented to enable more
e-prescribing vendors to route new prescriptions electronically to
mail-order pharmacies, but changes to support e-renewals lag.
Pharmacy processing of e-prescriptions
Most pharmacies received new e-prescriptions directly into their
pharmacy systems for processing. However, two mail-order
pharmacies and six community pharmaciesdincluding local and
national retailersdcontinued to manually enter all e-prescriptions.
Most of these pharmacies, though, were implementing new
systems with automated processing.
The majority of the remaining pharmacies processed
e-prescriptions similarly. Once the pharmacy staff were alerted to
a new e-prescription and opened it, the system attempted
to match the patient and physician. Staff sometimes had to
manually select the correct individual from a computer-generated
list of options or create a new proﬁle.
Staff then processed each prescription element, either clicking
on the information in the view screen to import it into the
corresponding pharmacy system ﬁeld or visually verifying the
information if the ﬁeld was auto-populated. Pharmacists
reported that the necessary ﬁelds were typically complete in
e-prescriptions, unlike paper prescriptions. When needed, phar-
macy staff typed in or edited text in a ﬁeld or selected an entry
from computer-generated options. Three prescription ﬁelds
commonly required manual manipulationdmedication name,
quantity, and patient instructions (also known as the Signatura
or ‘Sig’).
Medication name
When physicians select a medication, the data ﬁeld typically
contains a single string with the drug name, strength, and dosage
form, which is transmitted to the pharmacy along with the Food
and Drug Administration National Drug Code (NDC). Although
NDCs are used to standardize medication identiﬁcation across
systems using different drug-database vendors, there is no
central, up-to-date source for a unique NDC for each clinically
distinct drug.
7 If the NDCs in the e-prescription and the phar-
macy system do not match, the data cannot be auto-populated
and the pharmacist must rely on the transmitted information to
manually select a medication from the pharmacy database.
Moreover, both physician and pharmacist respondents
explained that physicians must select medications with more
speciﬁcity when e-prescribing, making decisions about pack-
aging, drug form, or other features that commonly are made by
pharmacists for hand-written prescriptions, sometimes leading
to more pharmacy follow-up. In an example provided by an
independent pharmacist, ‘A doctor might pick ‘minocycline
tablet, 100 mg.’ He wouldn’t intentionally select this because
it’s seven times more expensive than capsules.. In the past, the
doctor would have called in simply ‘minocycline.’ I would pick
‘capsules’ in the system because I know the cost difference.
When the doctor puts in ‘minocycline tablets,’ I, as a pharma-
cist, can’t change that. I have to give what they said.’ Physician
respondents conﬁrmed this problem, as one physician in a small
practice noted, ‘No longer now can I just say ‘potassium,’ I have
to pick if it’s a tablet, capsule, or liquiddyou used to just let the
pharmacist and patient deal with that.’
Physicians elaborated on the challenges in selecting the
intended medication given the overwhelming number of different
forms and strengths of medications available in a search query. A
physician respondent observed, ‘On my preference list, there are
19 adult and pediatric dosings for amoxicillin. If you don’t have
a preference list, you’re searching in the general database, which
is an absolute nightmare. There are two full screens with 60
entries for variations on the theme of amoxicillin. and that’s
a good situation.’ As another example of ‘over-speciﬁcation,’
physicians may have to choose from among different generic
drug manufacturers. Pharmacists noted that stores stock only
a limited number of manufacturers of any particular generic,
making it difﬁcult for the pharmacy system to match to the
manufacturer speciﬁed in the e-prescription. Physicians and
pharmacists also noted the serious problem of ‘fat ﬁngers,’ or
inadvertently selecting a drug with a similar spelling but
a different clinical purpose than the intended medication.
Quantity
Pharmacists and physicians both noted that physicians face
challenges accurately specifying quantities for prepackaged or
multi-use medicationsdsuch as pill packs, syringes, inhalers, or
creamsdin e-prescriptions. E-prescribing systems typically list
such medications by the container or package, rather than the
individual dosing units, which can cause physician confusion in
selecting the appropriate quantity. Pharmacists commented that
callbacks were typically unnecessary, but staff must be trained
to recognize and correct this type of problem, especially since
pharmacists must specify the quantity of the active ingredient
on insurance claims. Observed a pharmacist in a national chain
location, ‘With inhalers, prescribers usually enter the quantity
‘1,’ if you don’t change that, you’ll be billing (the insurer) for 1 g
but it weighs 17 g so you’ll be shorting yourself. It’s the same
with Enbrel, an injection medication that is 3.92 g. You have the
potential to lose $3000 if someone is not paying attention.’
Patient instructions
Nearly half of pharmacists noted that patient instructions
typically had to be rewritten for patients to understand. As an
independent pharmacist explained, ‘A lot of times we can’t copy
the directions word for word because the patient doesn’t
understand them, just like with paper prescriptions. We have to
go in and erase ‘t.i.d.’ and put in, ‘One tablet three times a day’.’
While some e-prescribing systems may facilitate writing
instructions in English, pharmacists indicated that, even when
not in Latin, Sigs often were written for the pharmacist and
needed editing to be more patient-friendly.
30
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Research and applicationsAbout a third of pharmacists noted another challenge: the
potential for physicians to provide additional instructions in
another ﬁeld, such as the extended instruction or comment box,
that contradict what is stored in the Sig ﬁeld. This sometimes
prompts callbacks, as a respondent at one local chain explained,
‘We’ll see ‘Take one tablet.’ Then it will say below in the notes
ﬁeld, ‘Take two tablets in the morning.’ It’s like the ﬁrst part is
automatically ﬁlled in for the doctor.. We normally look in
patient history.. If we see one tablet used in the past, then we
keep it at one tablet; otherwise we call the physician.’ While
some physicians conﬁrmed that this problem could arise in their
e-prescribing system, it is unclear how dependent this problem is
on speciﬁc system designs.
DISCUSSION
Study ﬁndings suggest that use of electronic transmission
features has matured relative to earlier research, with practices
and community pharmacies reporting few barriers to electronic
routing and receipt of new prescriptions. However, respondent
reports suggest that challenges related to e-renewals, mail-order
pharmacy connectivity, and pharmacy processing of select
e-prescription ﬁelds remain. These challenges likely will become
more salient for physician practices and pharmacies as
e-prescription volume accelerates in response to Federal incen-
tives. In addition, some physicians may be penalized inadver-
tently if they are unable to meet increasing threshold
requirements under the EHR Incentive Programs for the
proportion of prescriptions sent electronically because of chal-
lenges associated with mail-order prescriptions. While some
challenges may be mitigated as physicians and pharmacies gain
more experience, structural issues underlying these challenges
likely will need to be addressed directly. A broad group of public
and private stakeholders, including the Federal government, the
National Council for Prescription Drug Programs (NCPDP)
standards setting organization, vendors, and medical informatics
researchers would need to work together to help support these
efforts.
Increasing e-renewal reliability and efﬁciency
The e-renewal process may become more predictable if phar-
macies and practices with e-prescribing that are still faxing
renewals discontinue this practice when the Federal exemption
for computer-generated fax transmissions under the Medicare
Part D program expires on January 1, 2012.
31 Study ﬁndings
suggest that pharmacies and practices also may beneﬁt from
explicit guidance on incorporating the e-renewal process into
workﬂows, for example, through implementation guides, best-
practice tools, and targeted education, training, and support,
particularly once users have gained some e-prescribing experi-
ence.
32 33 There also may be opportunities to modify or enhance
underlying technical standards and physician and pharmacy
system design to better support electronic communication
during the renewal process, for example, providing alerts if
e-prescribers do not respond to renewal responses within
a speciﬁc time period or supporting standardized approaches for
pharmacy follow-up requests.
Improving mail-order pharmacy connectivity
Surescripts, mail-order pharmacies, and e-prescribing vendors are
working on network and system changes to increase the
proportion of practices that can communicate electronically
with mail-order pharmacies, and this transition could possibly
accelerate with the expiration of the Federal fax exemption.
Practices may beneﬁt from direct communication about these
changes and education on how to most efﬁciently process mail-
order prescriptions and renewals in the interim and after changes
are implemented.
Reducing the need for pharmacy editing of e-prescriptions
Study ﬁndings on challenges to reconciling prescription data
ﬁelds between practice and pharmacy systems are consistent
with other recent research.
7 34 To address challenges related to
drug identiﬁers, experts have recommended that NCPDP
consider using a new technical standard, RxNorm, a standard-
ized nomenclature for clinical drugs, in place of NDC codes as
the main identiﬁer.
7 RxNorm could help reduce drug selection
inefﬁciencies and potential errors by better conveying physi-
cians’ clinical intent without requiring them to over-specify
their choice and allowing pharmacists to use that information to
select the most appropriate medication. E-prescribing vendors
and drug database vendors also could explore ways to enhance
system interfaces and drug selection tools and promote best
practices so that physicians could more easily choose among
clinically appropriate options and convey the correct quantity
information regardless of dosage form.
To improve the quality of patient instructions in e-prescrip-
tions, the Structured and Codiﬁed Sig Format is being incorpo-
rated into the NCPDP SCRIPT e-prescribing transaction
standards.
34 Moving from free text to a structured format may
allow physicians to write more complete, clinically accurate, and
unambiguous Sigs. Experts recently recommended that the
Format be strengthened before it is made mandatory, and
suggest a solution to address the potential for conﬂicting Sig
information under the new standard.
34 Meanwhile, e-prescribing
vendors could explore ways to improve system design to miti-
gate the existing problems with conﬂicting Sigs. Other expert
recommendations include providing additional physician
training and developing best practices to encourage physicians to
send amended prescriptions to the pharmacy to avoid repeating
mistakes.
35e37
Supporting e-prescribing expansion
Additional research on the barriers to and facilitators of two-
way electronic communication will be increasingly important as
pharmacies and physician practices not only expand use of
existing e-prescribing features but also seek more electronic
communication tools. Technical standards to support additional
two-way electronic communication between practices and
pharmacies, for example, to change or cancel a prescription and
for clinical queries, have been incorporated into the
NCPDP SCRIPTstandard or are being developed; none are yet in
widespread use.
38
Study limitations
Because this is a qualitative study based on a small and
purposeful sample, ﬁndings cannot be statistically generalized to
all physicians and pharmacies using electronic prescription
routing. Moreover, because respondent identiﬁcation was
purposeful and participation was voluntary, the sample may
have been systematically biased about e-prescribing in a positive
or negative way. However, respondents typically identiﬁed both
facilitators of and barriers to effective electronic routing.
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